Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy

American Journal of Hypertension

Volumn 11, Issue 8 I, 1998, Pages 983-988

  De Mattia, Giancarlo ^b   Cassone Faldetta, Maria ^b   Bellini, Cesare ^b   Bravi, Maria C ^b   Laurenti, Oriana ^b   Baldoncini, Roberta ^b   Santucci, Anna ^b   Ferri, Claudio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE

Author keywords

Endothelins; Kidney diseases; Microalbuminuria; Non insulin dependent diabetes mellitus

Indexed keywords

ENDOTHELIN 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; HORMONE BLOOD LEVEL; HORMONE URINE LEVEL; HUMAN; HYPERTENSION; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; AGED; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENDOTHELIN-1; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 0031847324     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00094-6     Document Type: Article

References (26)

1. The United States Renal Data System: USRDS 1994 annual data report. The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 1994.
2. Mogensen CE, Keeane WF, Bennett PH, et al: Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995;346:1080-1084.
3. Mogensen CE: Management of the diabetic patients with elevated blood pressure or renal disease, in Laragh JH, Brenner BM (eds): Hypertension, Pathophysiology, Diagnosis and Management. Raven Press, New York, 1995, pp 2335-2365.
4. Koide H, Nakamura T, Ebihara I, et al: Endothelins in diabetic kidneys. Kidney Int 1995;48:S45-S49.
5. Vermes I, Sporen IFM, Kalsbeek-Batenburg EM, et al: In addition to von Willebrand factor and urinary albumin excretion, plasma endothelin is an indicator of endothelial dysfunction in diabetes mellitus. Diabetologia 1993;36:472-473.
6. King AJ, Brenner BM, Anderson S: Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 1989;256:F1051-F1058.
7. Simonson MS, Wann S, Mene P, et al: Endothelin stimulates phospolipase C, Na/H exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 1989;83:708-712.
8. Benini A, Zoja C, Corna D, et al: A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 1993;44:440-444.
9. Ferri C, Properzi G, Santucci A: Endothelin-1: a pathogenic factor in human disease or a physiologist's curiosity? High Blood Pressure 1995;4:1-19.
10. Abassi ZA, Klein H, Golomb E, et al: Urinary endothelin: a possible biological marker of renal damage. Am J Hypertens 1993;6:1046-1054.
11. Abassi ZA, Tate JE, Golomb E, et al: Role of neutral endopeptidase in the metabolism of endothelin. Hypertension 1992;20:89-95.
12. Brown M, Chou SJ, Porush JG: Endothelins and kidney disease. Nephron 1996;73:375-382.
13. Zoccali C, Leonardis D, Parlongo S, et al: Urinary and plasma endothelin-1 in essential hypertension and in hypertension secondary to renoparenchymal disease. Nephrol Dial Transplant 1995;10:1320-1323.
14. Ferri C, Carlomagno A, Baldoncini R, et al: Circulating endothelin-1 levels increase during euglycaemic hyperinsulinemic clamp in lean NIDDM men. Diabetes Care 1995;18:226-232.
15. Ferri C, Bellini C, Desideri G, et al: Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes 1995;44:431-437.
16. Ohta K, Hirata Y, Shichiri M, et al: Urinary excretion of endothelin-1 in normal subjects and in patients with renal diseases. Kidney Int 1991;39:307-311.
17. Takahashi K, Ghatei MA, Lam HC, et al: Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990;33:306-310.
18. Selvais PL, Kettelslegers JM, Buysschaert M, et al: Plasma endothelin-1 immunoreactivity is increased following long-term dietary supplementation with omega-3-fatty acids in microalbuminuric IDDM patients (letter). Diabetologia 1995;38:253.
19. Collier A, Leach JP, Jardine A, et al: Plasma endothelin-like immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care 1992;15:1038-1040.
20. Stehouwer CDA, Fischer HRA, Van Kujik AWR, et al: Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes 1995;44:561-564.
21. Ferri C, Pittoni V, Piccoli A, et al: Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab 1995;80:829-835.
22. Hu R, Levin ER, Pedram A, et al: Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes 1993;42:351-358.
23. Hattori Y, Kasai K, Makamura T, et al: Effects of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aorthic endothelial cells. Metab Clin Exp 1991;40:165-169.
24. Lam HC, Le JK, Kiang HG, et al: Does endothelin play a role in the pathogenesis of ealy diabetic nephropathy? J Cardiovasc Pharmacol 1995, 26(suppl 3)S479-S489.
25. Hoffman A, Grossman E, Goldstein DS, et al: Decreased levels of urinary endothelin-1 in patients with arterial hypertension: effects of sodium intake. Kidney Int 1994;45:556-560.
26. Lee YJ, Shin SJ, Tsai JH: Increased urinary endothelin-1 like immunoreactivity excretion in NIDDM patients with albuminuria. Diabetes Care 1994;17:253-266.